Dirk A. Bornemeier

Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects

Adam R. Johnson, A.G. Pavlovsky, Daniel F. Ortwine et al. · Journal of Biological Chemistry · 2007 · 211 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1,3,4-Oxadiazole, 1,3,4-thiadiazole, and 1,2,4-triazole analogs of the fenamates: in vitro inhibition of cyclooxygenase and 5-lipoxygenase activities

Diane H. Boschelli, David T. Connor, Dirk A. Bornemeier et al. · Journal of Medicinal Chemistry · 1993 · 202 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 1. Thiazolone and Oxazolone Series

Yuntao Song, David T. Connor, Robert Doubleday et al. · Journal of Medicinal Chemistry · 1999 · 130 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Synthesis, Structure−Activity Relationships, and in Vivo Evaluations of Substituted Di-<i>tert</i>-butylphenols as a Novel Class of Potent, Selective, and Orally Active Cyclooxygenase-2 Inhibitors. 2. 1,3,4- and 1,2,4-Thiadiazole Series

Yuntao Song, David T. Connor, Anthony D. Sercel et al. · Journal of Medicinal Chemistry · 1999 · 120 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Purification of a mammalian 5-lipoxygenase from rat basophilic leukemia cells

Andrew M. Goetze, Liz Fayer, Jennifer B. Bouska et al. · Prostaglandins · 1985 · 90 citations

Life Sciences, Biochemistry, Cell Biology +8